BRT-logo-final.png
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 09, 2021 11:58 ET | BioRestorative Therapies, Inc
MELVILLE, N.Y., Aug. 09, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
RenovaCare Appoints Dr. Lydia M. Evans to Its Board of Directors and Increases Board Membership
August 04, 2020 08:30 ET | RenovaCare, Inc.
ROSELAND, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London
March 30, 2020 08:32 ET | RenovaCare, Inc.
ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
AntiCancer PDOX Reaches Series A Financing Target, Appoints Board
June 01, 2017 16:24 ET | AntiCancer PDOX, Inc.
CHICAGO, June 01, 2017 (GLOBE NEWSWIRE) -- ASCO 2017 -- AntiCancer PDOX, Inc. announced today that it has reached its original Series A financing target and appointed its Board of...
PreveCeutical Announces the Appointment of Dr. Makarand Jawadekar as Chief Science Officer; Announces Accelerated Pre-Clinical Program for Nature Identical Peptide, Similar to the Active Found in Caribbean Blue Scorpion Venom
August 16, 2016 11:38 ET | PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 16, 2016 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. ("PreveCeutical," or the "Company"), a health and wellness company focused on utilizing nature and science...